Effectiveness of imazodan for treatment of chronic congestive heart failure
- 1 September 1991
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (6) , 631-636
- https://doi.org/10.1016/0002-9149(91)90356-p
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart FailureJAMA, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Hemodynamic, pharmacokinetic and clinical response to CI-930 in congestive heart failure due to ischemic or dilated cardiomyopathyThe American Journal of Cardiology, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failureThe American Journal of Cardiology, 1986
- Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failureJournal of the American College of Cardiology, 1984
- Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performanceThe American Journal of Cardiology, 1984
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978